The Effectiveness of Cyclic Desogestrel Therapy for Abnormal Uterine Bleeding Associated With Anovulation: a Non-inferiority Double Blinded Randomized Control Trial
Status: Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 28 Aug 2018
Price : $35 *
At a glance
- Drugs Desogestrel (Primary) ; Medroxyprogesterone
- Indications Metrorrhagia
- Focus Therapeutic Use
- Acronyms SI-AUB-RCT
- 31 Aug 2018 Biomarkers information updated
- 20 Aug 2018 Planned End Date changed from 1 Dec 2015 to 1 Dec 2018.
- 20 Aug 2018 Status changed from recruiting to active, no longer recruiting.